SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-028243
Filing Date
2011-05-11
Accepted
2011-05-11 17:14:41
Documents
8
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 v221875_10q.htm 10-Q 394135
2 v221875_ex10-30x6.htm EX-10.30.6 24775
3 v221875_ex10-30x7.htm EX-10.30.7 43554
4 v221875_ex10-30x8.htm EX-10.30.8 38985
5 v221875_ex31-1.htm EX-31.1 14908
6 v221875_ex31-2.htm EX-31.2 15039
7 v221875_ex32-1.htm EX-32.1 5818
8 v221875_ex32-2.htm EX-32.2 6363
  Complete submission text file 0001144204-11-028243.txt   544660
Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 11832811
SIC: 2834 Pharmaceutical Preparations